Press Releases

• Biogen: Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents With C3G or Primary IC-MPGN More
• Broad Institute: Software Rapidly Tracks Viral Variants With High Accuracy More
• Dana-Farber Cancer Institute: Making Invisible Cancers Visible - Study Suggests a New Route to Turn ‘Cold’ Tumors ‘Hot’ More
• Dana-Farber Cancer Institute: Rare Inherited EGFR Mutation Linked to Dramatically Increased Lung Cancer Risk More
• Hemab Therapeutics: First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding More
• Insilico Medicine: Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study More
• Sempresto: Positive FDA Type B Pre-IND Meeting Response for Smartphone-Integrated Epinephrine Auto-Injector More
• SignaBlok: Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease More
• Xenon: Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program More More

Financial News

• AVAVA: $45 Million Financing Led by Catalio Capital Management to Accelerate Next Phase of Growth More
• Biotech News September 17, 2026: Xenon XENE Files Azetukalner NDA; Nuvation NUVB Wins FDA Label Update More
• Dyne Therapeutics: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• Moderna Stock More Than Doubled in a Month. Now Comes the Hard Part More
• More on French Biotech With Cambridge Office Weighing U.S. IPO After Sanofi Investment More*
• Ocular Therapeutix: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• Robigo and Leaps by Bayer: Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs More
• Takeda: Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems More
• The Largest Med-device Firms in Mass. Collectively Increased Revenue in 2025 More*

Media/Misc Coverage

• Big4Bio CEO Weekly Q&A: Dr. Manish Arora, Founder and CEO, LinusBio More
  
• BioPharmGuy News: Lilly Domination, Novo Truncation, Bodega Peptides, Of Mice & Mankind More
  
• Biotech & Pharma Updates | September 17, 2026 More
  
• Charles River Celebrates Thirty Years of Biotech Innovation More
• Subscribe to LifeSci Startup for Updates on US Startups More
• When Drug Development Becomes Personal - Meg Gill’s Mission to Find a Treatment for Her Daughter More

Career Moves

• Biopharma Hiring Hotspots: States, Disciplines Where Demand Is Highest More
• Ernexa Therapeutics: Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors More
• Life Sciences Restructurings Hit Massachusetts as Patent Cliffs, M&A Deals Reshape Workforce More*
• OPPORTUNITY: Chief Financial Officer, Boston/San Diego More
• OPPORTUNITY: SVP, Regulatory and Quality Assurance, Boston/San Diego More
• OPPORTUNITY: Head of Global Research & Development, Columbia, MD More
• Slone Partners: Behind the Search’ - A Conversation with George Quinn, Partner, Fractional Talent More
• Slone Partners: ICYMI - How to Keep Your Highest Performers Engaged More
• The Top Life Sciences Firms in Mass. Employ More People Than Last Year More*

• Biotech Week Boston 2026 Sept 22-25
• Webinar: Selecting Rodent Models in Metabolic Disease Sept 22
• Discovery on Target Sept 28-Oct 1
• Biocom’s HR Conference for Life Science Sept 30
• Life Sciences Future Sept 30-Oct 1
• Biocom’s San Diego Life Science CEO Summit Oct 8
• MassBioEd’s 25th Anniversary Gala Oct 21
• Biocom’s Bay Area CEO Summit Oct 23
• Biocom’s Greater LA CEO Summit Oct 27
• BioFuture Oct 27-28
• PODD: Partnership Opportunities in Drug Delivery Oct 29-30
• 23rd Annual Pantheon Awards Nov 12

Companies

Boston Sponsors